InsidersTradesSigma
선바이오 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 선바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 선바이오 has recorded 4 public disclosures. Market capitalisation: €78.7bn. The latest transaction was filed on 9 June 2026 (Purchase). Among the most active insiders: 노광. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
€72,519
4 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,771 of 28,021 companies
56.0
score / 100
Value42
Quality70
FCF yld0.7%
Earn yld3.5%
EV/EBITDA18.1x
ROE35%
Gross mgn61%
Net mgn20%
Debt/EBITDA4.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 June 2026
Declarations4 total
4 of 4 declarations
About 선바이오
선바이오 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.